Jean Arkedis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Jean Arkedis has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jessica Cohen
Harvard T.H. Chan School of Public Health, Boston, Massachusetts
3 shared publications - Oliver Sabot
Clinton Health Access Initiative, 383 Dorchester Avenue, Suite 400, Boston, MA 02127, USA
3 shared publications - Julius J. Massaga
National Institute for Medical Research, P.O. Box 9653, Dar es Salaam, Tanzania
2 shared publications - Peter S. Larson
Injury Prevention Center, University of Michigan-Ann Arbor, Ann Arbor, Michigan, USA
2 shared publications - Prashant Yadav
University of Michigan
2 shared publications - Alexandra Morris
Clinton Health Access Initiative, 383 Dorchester Avenue, Suite 400, Boston, MA 02127, USA
1 shared publication
Latest Publications
- Open Access
- 18 December 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 526
Diffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adopters
Many households in sub-Saharan Africa utilize the private sector as a primary source of treatment for malaria episodes. Expanding access to effective treatment in private drug shops may help reduce incidence of severe disease and mortality. This research leveraged a longitudinal survey of stocking of subsidized artemisinin combination therapies (ACTs), an effective anti-malarial, in Accredited Drug Dispensing Outlets (ADDOs) in two regions of Tanzania. This provided a unique opportunity to explore shop and market level determinants of product diffusion in a developing country retail market.
- 18 December 2013
- Published by Springer Nature in BMC Health Services Research
- Vol. 13 (1) , 526
Open AccessDiffusion of subsidized ACTs in accredited drug shops in Tanzania: determinants of stocking and characteristics of early and late adopters
Many households in sub-Saharan Africa utilize the private sector as a primary source of treatment for malaria episodes. Expanding access to effective treatment in private drug shops may help reduce incidence of severe disease and mortality. This research leveraged a longitudinal survey of stocking of subsidized artemisinin combination therapies (ACTs), an effective anti-malarial, in Accredited Drug Dispensing Outlets (ADDOs) in two regions of Tanzania. This provided a unique opportunity to explore shop and market level determinants of product diffusion in a developing country retail market.
- Open Access
- 28 August 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 299
Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania
The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-national subsidy
- 28 August 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 299
Open AccessTrends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania
The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-national subsidy
- Open Access
- 23 March 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 83
Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda
Increasing affordability of artemisinin combination therapy (ACT) in the African retail sector could be critical to expanding access to effective malaria treatment, but must be balanced by efforts to protect the efficacy of these drugs. Previous research estimates ACT adherence rates among public sector patients, but adherence among retail sector purchasers could differ substantially. This study aimed to estimate adherence rates to subsidized, over-the-counter ACT in rural Uganda.
- 23 March 2012
- Published by Springer Nature in Malaria Journal
- Vol. 11 (1) , 83
Open AccessDo patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda
Increasing affordability of artemisinin combination therapy (ACT) in the African retail sector could be critical to expanding access to effective malaria treatment, but must be balanced by efforts to protect the efficacy of these drugs. Previous research estimates ACT adherence rates among public sector patients, but adherence among retail sector purchasers could differ substantially. This study aimed to estimate adherence rates to subsidized, over-the-counter ACT in rural Uganda.